#128 Parenteral Medicine Q&A Updates Part 1 and 2

Watch Dr. Anderson record Part 1 LIVE on Tuesday June 17th, 2025 AND Part 2 Thursday June 19th, 2025 @ 5:30 PM PST

If you want to attend both live recordings you MUST register for BOTH days

Program Summary:

Parenteral medicine is an ever-evolving practice. New products, changes in legal requirements, updated practice guidelines, and other factors can make it difficult to keep current. This presentation is designed to answer questions commonly posed in parenteral medicine practice. Updates and clarifications in clinical management, administration guidelines, safety, legal parameters, and other factors will be discussed. This “Q&A” regarding parenteral medicine will be given in two two-hour CME presentations.

Learning Objectives:

• Define “Parenteral Medicine”

• Describe the current legal climate for nutritional infusions

• Describe safety parameters around the various agents discussed

• Discuss the relative indications for the agents discussed

CME Effective Date:

Part 1: Live Event June 17th, 2025

Part 2:  Live Event June 19th, 2025

CME Expiration Date:

Part 1: Live Event July 17th, 2025

Part 2: Live Event July 19th, 2025

Educational Credits:

Part 1:

2.0 AMA/PRA Category 1 CME Credit™
2.0 Nursing Contact Hours (2.0 Pharmacologic Hours)

Part 2:

2.0 AMA/PRA Category 1 CME Credit™
2.0 Nursing Contact Hours (2.0 Pharmacologic Hours)

Target Audience:

This program is intended for: Physicians (MD, ND, Other), Nurses, Nurse Practitioners, and Other Healthcare professionals

Conflict of Interest Disclosure Policy

Identify, Mitigate, and Disclose Relevant Financial Relationships 

Many healthcare professionals have financial relationships with ineligible companies.  These relationships must not be allowed to influence accredited continuing education.  The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company.  As an accredited provider FCM collects information from planners, faculty and others in control of educational content and conducts an extensive review process.  Financial relationships are identified, reviewed and mitigated.  In some cases. speakers and committee members may be excluded.  All relevant financial relationships are disclosed to the learner below as required by the ACCME

Disclosures:

Planner/Presenter: Dr. Paul Anderson discloses the following: NFH – Vitazan; Science Advisory Board Member, MD Lifespan; Science Advisory Board Member, Priority One; Formulation Advisor.

Reviewers: Kenneth Meyer discloses no financial relationships with any ineligible companies.

Accreditation Statement:

Washington State ND’s: This CME is co-accredited by WANP which allows WA State Category-1 CME Credit for WA Licensed ND’s

In support of improving patient care, this activity has been planned and implemented by the Foundation for Care Management (FCM) and P S Anderson LLC. FCM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Part 1 of this program is approved for 2.0 AMA Category 1 Credits^TM
This program is approved for 2.0 Nursing Contact Hours(2.0 Pharmacologic hours).

Part 2 of this program is approved for 2.0 AMA Category 1 Credits^TM
This program is approved for 2.0 Nursing Contact Hours(2.0 Pharmacologic hours).

Healthcare providers should only claim credit commensurate with the extent of their participation in this activity.